Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microtransplantation for Ovarian Cancer
NCT05095558Phase 2Unknown
- Sponsor
- 307 Hospital of the People's Liberation Army
- Start
- Oct 2021
- Primary completion
- Oct 2023
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of peripheral blood stem cells in ovarian cancer, sponsored by 307 Hospital of the People's Liberation Army. Status: unknown.
02
Drugs
peripheral blood stem cells
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT05095558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05095558.